As the potential benefit of a KIR-ligand mismatch is not very well established in MM, we recently addressed this question in a series of in vitro studies in which we were especially interested in the functional relevance of KIR-ligand mismatching for highly activated NK cells. The gene discussed is KIR3DL1; the disease is Miyoshi myopathy.